Health Trials

Resectable Stage Ib Iii Non Squamous Non Small Cell Lung Cancer

1

Review clinical trials related to Resectable Stage Ib Iii Non Squamous Non Small Cell Lung Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

IBI363 Combined With Chemotherapy or Pembrolizumab Combined With Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer

This study is a randomized, open-label Phase 2 study to compare the efficacy and safety of IBI363 Combined with Chemotherapy or Pembrolizumab Combined with Chemotherapy as Neoadjuvant Therapy in Resectable Stage IB-III Non-Squamous Non-Small Cell Lung Cancer.

Participants needed: 170
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Innovent Biologics (Suzhou) Co. Ltd.Updated: Sep 30, 2025Locations: 1
Eligibility criteria

Males and Females, age ≥18 years and ≤75 years; [+7]

Histologically confirmed the presence of small cell lung cancer, neuroendocrine... [+12]

Read more